Skip to main navigation
VIR logo

Press Releases

Press Releases

Date Title
2/11/21 Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
2/1/21 Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics
1/27/21 Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
1/26/21 Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen
1/12/21 Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
1/12/21 Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
1/6/21 Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
1/5/21 Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 18 of 18

Vir - Investor Relations Menu

  • Corporate Governance
    • Charters & Governance
    • Leadership
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Investor Resources
    • FAQ
    • Investor Contact
    • Email Alerts
  • Financial Information
    • Quarterly Results

Vir - Top Menu

  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts

Vir - Investor Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Investor Contact

Vir - Top Menu

  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts

vir logo white

Vir Biotechnology, Inc.
499 Illinois Suite 500
San Francisco, CA 94158
415-906-4324

email: info@vir.bio

  • LinkedIn
  • Twitter
©  Vir Biotechnology All rights reserved.
  • Privacy Policy
  • Terms of Use